Skip to main content

Table 2 Relationships between TIN density and clinical characteristics in TGCT patients (N = 102)

From: Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor

   TIN density
Low (N = 81) High (N = 21) P value
Age (years ± SD)a   34.7 ± 11.2 31.7 ± 12.3 0.1438
Tumor marker
 LDH (N = 99) Normal 41 (42%) 7 (7%) 0.1768
High 38 (38%) 13 (13%)  
 AFP (N = 99) Normal 55 (56%) 12 (12%) 0.2449
High 23 (23%) 9 (9%)  
 βhCG (N = 101) Normal 31 (31%) 7 (7%) 0.6484
High 49 (48%) 14 (14%)  
T stage T1 50 (49%) 8 (8%) 0.0513
T2-T4 31 (30%) 13 (13%)  
S stage (N = 97) S0-1 58 (60%) 10 (10%) 0.0275
S2-3 19 (20%) 10 (10%)  
Stage Stage I 65 (64%) 7 (7%) <0.0001
Stage II-III 16 (15%) 14 (14%)  
IGCCC riskb Good 10 (33%) 8 (27%) 0.8051
Intermediate 4 (13%) 3 (10%)  
Poor 2 (7%) 3 (10%)  
  1. TIN tumor-infiltrating neutrophil, TGCT testicular germ cell tumor, LDH lactate dehydrogenase, αFP α feto protein, βhCG β human chorionic gonadotropin, IGCCC International Germ Cell Consensus Classification. aWilcoxon rank-sum test was used for statistical analysis in evaluating age between low and high density groups. Pearson’s chi square test was performed for other parameters. bNote that the IGCCC risk classification is applied only in patients with metastatic TGCT patients